Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Bavarian Nordic A/S Stock

Price
Target price
€36.93

€36.93

0.980%
0.36
0.980%
€50.00
 
23.08.24 / Tradegate WKN: 917165 / Symbol: BAVA / Name: Bavarian Nordic / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Bavarian Nordic A/S in the next few years
Wizard

Description Bavarian Nordic

Bavarian Nordic is a Danish biotechnology company that specializes in the research, development, and manufacturing of vaccines for infectious diseases and cancer immunotherapies. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Bavarian Nordic is publicly traded on the NASDAQ Copenhagen stock exchange under the symbol BAVA. Its shares are also traded over the counter in the United States under the symbol BVNRY.

The company's primary vaccine products are focused on preventing infectious diseases such as smallpox, shingles, and Ebola. It has also developed cancer immunotherapies, including a prostate cancer vaccine currently in clinical trials.

Bavarian Nordic has manufacturing facilities in Denmark and the United States, and has collaborations with multiple government agencies and private pharmaceutical companies. It is considered a small-cap company with a market capitalization of around $3 billion as of 2021.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Bavarian Nordic A/S is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Bavarian Nordic

sharewise wants to provide you with the best news and tools for Bavarian Nordic, so we directly link to the best financial data sources.

Financials

News

Broker